Overview
Status
Active
Registry date
2017-07-25
Share capital
5,000.00 PLN
Registered address
ul. Grzybowska 87, 00-844 Warszawa, Poland
Email
Electronic delivery address
AE:PL-25589-94642-FHAHG-28
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 164 days early.
- 202506/02/2026
- 202427/02/2025
- 202309/02/2024
- 202230/01/2023
- 202110/03/2022
- 202018/02/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 14.53kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 4.33kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 9.75kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 14.47kMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Volodymyr Royko – President of the Management Board
Manner of representation
Each member of the management board is authorised to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Nataliya Royko | 10 | $135.06 | 10% |
Volodymyr Roykoage 66 | 90 | $1,215.56 | 90% |
Volodymyr Royko and Nataliya Royko hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-08-01.
26 1160 2202 0000 0003 3083 1737
57 1160 2202 0000 0003 3083 1664
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl | ||
| Optimedussp. z o.o. | $1.00 | optimedus.pl |
FAQ
The main business activity of Optomed focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on July 25, 2017.
The headquarters is located at: ul. Grzybowska 87, 00-844 Warszawa.
The management board consists of: Volodymyr Royko (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $14,534 in 2025, which is an increase of 13.8% compared to 2024.
Yes, the company recorded a net profit of $4,334 in 2025, meaning the company increased its profit by 2.4%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $6,456 in 2025, representing 66% of all operating expenses.
Last updated: 2026-04-24